COMMUNIQUÉS West-GlobeNewswire

Alpha Pro Tech, Ltd. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2018

05/03/2019 - 22:15

Revenue for the fourth quarter of 2018 was $11.0 million, an increase of 10% compared to $9.9 million for the fourth quarter of 2017. Revenue for the year ended December 31, 2018 increased 5.9% to $46.6 million, [...]

Corvus Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference

05/03/2019 - 22:15

BURLINGAME, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]

DBV Technologies Reports Full Year 2018 Financial Results and Provides Operational Update

05/03/2019 - 22:10

Montrouge, France, March 5, 2019 DBV Technologies Reports Full Year 2018 Financial Results and Provides Operational Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical- [...]

DBV Technologies annonce ses résultats financiers pour l’exercice 2018 et fait un point sur ses activités

05/03/2019 - 22:10

Montrouge, France, 5 mars (22h10 CET) 2019 DBV Technologies annonce ses résultats financiers pour l’exercice 2018 et fait un point sur ses activités DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT [...]

IRIDEX Announces 2018 Fourth Quarter and Full Year Financial Results

05/03/2019 - 22:08

MOUNTAIN VIEW, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended December 29, 2018. Fourth Quarter Highlights Cyclo G6 ® [...]

Prothena to Participate in Upcoming March Healthcare Conferences

05/03/2019 - 22:05

DUBLIN, Ireland, March 05, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, today announced that members of its senior management team will present and participate [...]

Aravive Announces Participation at Cowen and Company 39th Annual Health Care Conference

05/03/2019 - 22:05

HOUSTON, March 05, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, announced that company management will participate at the following upcoming investor conference: [...]

Tabula Rasa HealthCare Announces Acquisition of PrescribeWellness Expanding its Medication Risk Mitigation Offering

05/03/2019 - 22:05

MOORESTOWN, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that it has acquired [...]

CytomX to Present at Upcoming Healthcare Conferences

05/03/2019 - 22:05

SOUTH SAN FRANCISCO, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]

Kura Oncology Reports Fourth Quarter and Full Year 2018 Financial Results

05/03/2019 - 22:03

– Registration-directed trial of tipifarnib in HRAS mutant HNSCC underway – – Data from three ongoing Phase 2 trials of tipifarnib anticipated this year – – Third drug candidate menin-MLL inhibitor KO-539 poised to [...]

Sarepta Therapeutics Announces Proposed $350,000,000 Public Offering of Common Stock

05/03/2019 - 22:02

CAMBRIDGE, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it is offering to sell, subject to market [...]

Cara Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019

05/03/2019 - 22:01

STAMFORD, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on the [...]

Mersana Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

05/03/2019 - 22:01

CAMBRIDGE, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (Nasdaq:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]

Ziopharm Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

05/03/2019 - 22:01

- Phase 1 Trial of Sleeping Beauty -TCR-T cell therapy for patients with solid tumors to begin at National Cancer Institute in mid-2019 – - Third-generation Sleeping Beauty CD19-specific CAR-T U.S. trial to begin in [...]

CymaBay Announces Proposed Public Offering of Common Stock

05/03/2019 - 22:01

NEWARK, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]

Gritstone Oncology to Present at Two Upcoming Investor Conferences in March

05/03/2019 - 22:00

EMERYVILLE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]

Dermira to Present at the Cowen and Company 39th Annual Health Care Conference

05/03/2019 - 22:00

MENLO PARK, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Crown Bioscience and The Jackson Laboratory Collaboration Enables Global Access to FATZO Mouse Model

05/03/2019 - 21:35

Continued Collaboration Facilitates Global Distribution of Obesity, Metabolic Disease, and NASH Model and Priority Supply to CrownBio’s World-Class Cardiovascular, Obesity, and Metabolic Disease Platform SAN DIEGO, [...]

Christina Lake Cannabis Announces License Application

05/03/2019 - 18:55

VANCOUVER, British Columbia, March 05, 2019 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (“ CLC ” or the “ Company ”) is pleased to announce that it submitted its application for a Standard Cultivation License [...]